About
Maxim Kholin is a biotech entrepreneur and the co-founder and Chief Corporate Development Officer of Gero, a Singapore-headquartered AI-driven longevity biotechnology company. At Gero he leads corporate affairs, legal strategy, fundraising, and investor relations. He is also a visible public representative of the company in the longevity ecosystem through conference speaking and industry association participation.
Areas of interest
longevitybiotechartificial intelligencedrug discoveryaging biologyage-related diseasespharmaceutical partnershipsreal-world health data